The non-selective synthetic cannabinoids (CP55,940 and WIN55,212-2) can exert significant anti-inflammatory effects on cultured IL-1β RA FLS by inhibiting IL-6 and IL-8 via a non-CB1R/CB2R-mediated mechanism [62]. This evidence concerns the gene IL1B and rheumatoid arthritis.